公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2019 | High PD-L1 expression correlates with primary resistance to EGFR-TKIs in treatment naïve advanced EGFR-mutant lung adenocarcinoma patients | Hsu K.-H.; Huang Y.-H.; Tseng J.-S.; Chen K.-C.; Ku W.-H.; KANG-YI SU ; Chen J.J.W.; HUEI-WEN CHEN ; SUNG-LIANG YU ; Yang T.-Y.; Chang G.-C. | Lung Cancer | 64 | 52 | |
2016 | Higher frequency but random distribution of EGFR mutation subtypes in familial lung cancer patients | Hsu K.-H.; Tseng J.-S.; Wang C.-L.; Yang T.-Y.; Tseng C.-H.; Chen H.-Y.; Chen K.-C.; Tsai C.-R.; Yang C.-T.; SUNG-LIANG YU ; KANG-YI SU ; CHONG-JEN YU ; CHAO-CHI HO ; Hsia T.-C.; Wu M.-F.; Chiu K.-L.; Liu C.-M.; PAN-CHYR YANG ; Chen J.J.W.; Chang G.-C. | Oncotarget | 9 | 9 | |
2010 | HLJ1 is a novel caspase-3 substrate and its expression enhances UV-induced apoptosis in non-small cell lung carcinoma | Lin S.-Y.; Hsueh C.-M.; SUNG-LIANG YU ; Su C.-C.; Shum W.-Y.; Yeh K.-C.; Chang G.-C.; Chen J.J.W. | Nucleic Acids Research | 27 | 25 | |
2016 | HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms | Chen C.-H.; Chang W.-H.; KANG-YI SU ; Ku W.-H.; Chang G.-C.; Hong Q.-S.; Hsiao Y.-J.; Chen H.-C.; Chen H.-Y.; Wu R.; PAN-CHYR YANG ; Chen J.J.W.; SUNG-LIANG YU | Oncogene | 21 | 21 | |
2017 | HOXA5 and p53 cooperate to suppress lung cancer cell invasion and serve as good prognostic factors in non-small cell lung cancer | Chang C.-J.; Chen Y.-L.; Hsieh C.-H.; Liu Y.-J.; SUNG-LIANG YU ; Chen J.J.W.; Wang C.-C. | Journal of Cancer | 33 | 33 | |
2015 | HOXA5 inhibits metastasis via regulating cytoskeletal remodelling and associates with prolonged survival in non-small-cell lung carcinoma | Wang C.-C.; KANG-YI SU ; Chen H.-Y.; Chang S.-Y.; Shen C.-F.; Hsieh C.-H.; Hong Q.-S.; Chiang C.-C.; Chang G.-C.; SUNG-LIANG YU ; Chen J.J.W. | PLoS ONE | 38 | 32 | |
2015 | Identification of Five Driver Gene Mutations in Patients with Treatment-Naïve Lung Adenocarcinoma in Taiwan | Hsu K.-H.; CHAO-CHI HO ; Hsia T.-C.; Tseng J.-S.; KANG-YI SU ; Wu M.-F.; Chiu K.-L.; Yang T.-Y.; Chen K.-C.; Ooi H.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; KUAN-YU CHEN ; WEI-YU LIAO ; JIN-YUAN SHIH ; SUNG-LIANG YU ; CHONG-JEN YU ; PAN-CHYR YANG ; Chang G.-C. | PLoS ONE | 98 | 92 | |
2008 | Intra-abdominal adhesion formation induces anti-oxidative injury, enhances cell proliferation, and prevents complement-mediated lysis | SUNG-LIANG YU ; Singh S.; HUEI-WEN CHEN ; Chen H.-Y.; Chen J.J.W.; WEN-JONE CHEN ; Chen H.-S.; SHYR-CHYR CHEN | Wound Repair and Regeneration | 5 | 4 | |
2020 | Landscape of mitochondria genome and clinical outcomes in stage 1 lung adenocarcinoma | Raghav L.; Chang Y.-H.; Hsu Y.-C.; Li Y.-C.; Chen C.-Y.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Chuang C.-Y.; Lee M.-H.; Wang C.-L.; HUEI-WEN CHEN ; SUNG-LIANG YU ; SHENG-FANG SU ; Yuan S.-S.; Chen J.J.W.; Ho S.-Y.; Li K.-C.; PAN-CHYR YANG ; Chang G.-C.; Chen H.-Y. | Cancers | 8 | 8 | |
2008 | MicroRNA Signature Predicts Survival and Relapse in Lung Cancer | SUNG-LIANG YU ; HSUAN-YU CHEN; Chang G.-C.; Chen C.-Y.; HUEI-WEN CHEN ; Singh S.; Cheng C.-L.; CHONG-JEN YU ; Lee Y.-C.; Chen H.-S.; Su T.-J.; Chiang C.-C.; Li H.-N.; Hong Q.-S.; Su H.-Y.; Chen C.-C.; Chen, W.-J.; Liu C.-C.; Chan W.-K.; WEI J. CHEN ; Li K.-C.; Chen J.J.W.; PAN-CHYR YANG | Cancer Cell | 725 | 672 | |
2008 | Modulation of the expression of the invasion-suppressor CRMP-1 by cyclooxygenase-2 inhibition via reciprocal regulation of Sp1 and C/EBPα | Wu C.-C.; Lin J.-C.; Yang S.-C.; Lin C.-W.; Chen J.J.W.; JIN-YUAN SHIH ; Hong T.-M.; PAN-CHYR YANG | Molecular Cancer Therapeutics | 16 | 16 | |
2006 | Multifunctional transcription factor YY1: A therapeutic target in human cancer? | Wang C.-C.; Chen J.J.W.; PAN-CHYR YANG | Expert Opinion on Therapeutic Targets | 46 | 39 | |
2006 | A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma | Tsai M.-F.; Wang C.-C.; Chang G.-C.; Chen C.-Y.; Chen H.-Y.; Cheng C.-L.; Yang Y.-P.; Wu C.-Y.; Shih F.-Y.; Liu C.-C.; Lin H.-P.; Jou Y.-S.; Lin S.-C.; CHUNG-WU LIN ; WEI J. CHEN ; Chan W.-K.; Chen J.J.W.; PAN-CHYR YANG | Journal of the National Cancer Institute | 101 | 98 | |
2012 | A novel function of YWHAZ/β-catenin axis in promoting epithelial-mesenchymal transition and lung cancer metastasis | Chen C.-H.; Chuang S.-M.; Yang M.-F.; Liao J.-W.; SUNG-LIANG YU ; Chen J.J.W. | Molecular Cancer Research | 77 | 78 | |
2016 | Oncogenic miR-137 contributes to cisplatin resistance via repressing CASP3 in lung adenocarcinoma | Su T.-J.; Ku W.-H.; Chen H.-Y.; Hsu Y.-C.; Hong Q.-S.; Chang G.-C.; SUNG-LIANG YU ; Chen J.J.W. | American Journal of Cancer Research | 22 | ||
2015 | Opposite Effects of M1 and M2 Macrophage Subtypes on Lung Cancer Progression | ANG YUAN ; Hsiao Y.-J.; Chen H.-Y.; HUEI-WEN CHEN ; CHAO-CHI HO ; Chen Y.-Y.; Liu Y.-C.; Hong T.-H.; SUNG-LIANG YU ; Chen J.J.W.; PAN-CHYR YANG | Scientific Reports | 258 | 229 | |
2015 | PARVA promotes metastasis by modulating ILK signalling pathway in lung adenocarcinoma | Huang A.-H.; SZU-HUA PAN ; Chang W.-H.; Hong Q.-S.; Chen J.J.W.; SUNG-LIANG YU | PLoS ONE | 24 | 24 | |
2016 | Phosphatase of regenerating liver-3 inhibits invasiveness and proliferation in non-small cell lung cancer by regulating the epithelial-mesenchymal transition | Lin S.-Y.; Lee Y.-X.; SUNG-LIANG YU ; Chang G.-C.; Chen J.J.W. | Oncotarget | 7 | 7 | |
2016 | Predilection of contralateral upper lung metastasis in upper lobe lung adenocarcinoma patients | Huang Y.-H.; Hsu K.-H.; Tseng J.-S.; Chen K.-C.; KANG-YI SU ; Chen H.-Y.; Chang C.-S.; Chen J.J.W.; SUNG-LIANG YU ; HUEI-WEN CHEN ; Yang T.-Y.; Chang G.-C. | Journal of Thoracic Disease | 2 | 2 | |
1998 | Profiling expression patterns and isolating differentially expressed genes by cDNA microarray system with colorimetry detection | Chen J.J.W.; Wu R.; PAN-CHYR YANG ; Huang JY; Sher YP; Han MH; Kao WC; Lee PJ; Chiu TF; Chang F; Chu YW; Wu CW; Peck K | Genomics | 204 | 172 |